These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34479168)

  • 1. Higher motor cortical excitability linked to greater cognitive dysfunction in Alzheimer's disease: results from two independent cohorts.
    Zadey S; Buss SS; McDonald K; Press DZ; Pascual-Leone A; Fried PJ
    Neurobiol Aging; 2021 Dec; 108():24-33. PubMed ID: 34479168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Assessment of Cortical Excitability in Alzheimer's Dementia and Its Association with Clinical Symptoms: A Systematic Review and Meta-Analyses.
    Joseph S; Patterson R; Wang W; Blumberger DM; Rajji TK; Kumar S
    J Alzheimers Dis; 2022; 88(3):867-891. PubMed ID: 34219724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Resting Motor Threshold correlate with severity of Alzheimer's disease?
    Uehara MA; Francisco CO; Lithgow B; Koski L; Moussavi Z
    Annu Int Conf IEEE Eng Med Biol Soc; 2022 Jul; 2022():4383-4386. PubMed ID: 36086598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor cortical excitability and paired-associative stimulation-induced plasticity in amnestic mild cognitive impairment and Alzheimer's disease.
    Meder A; Liepelt-Scarfone I; Sulzer P; Berg D; Laske C; Preische O; Desideri D; Zipser CM; Salvadore G; Tatikola K; Timmers M; Ziemann U
    Clin Neurophysiol; 2021 Sep; 132(9):2264-2273. PubMed ID: 33612394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical excitability and plasticity in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis of transcranial magnetic stimulation studies.
    Chou YH; Sundman M; Ton That V; Green J; Trapani C
    Ageing Res Rev; 2022 Aug; 79():101660. PubMed ID: 35680080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between motor cortex excitability and severity of Alzheimer's disease: a transcranial magnetic stimulation study.
    Khedr EM; Ahmed MA; Darwish ES; Ali AM
    Neurophysiol Clin; 2011 Jul; 41(3):107-13. PubMed ID: 21784322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological differences in cortical excitability in different forms of dementia: A transcranial magnetic stimulation and laboratory biomarkers study.
    Khedr EM; Ahmed OG; Sayed HM; Abo-Elfetoh N; Ali AM; Gomaa AM
    Neurophysiol Clin; 2020 Jul; 50(3):185-193. PubMed ID: 32591186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer's dementia.
    Ahmed MA; Darwish ES; Khedr EM; El Serogy YM; Ali AM
    J Neurol; 2012 Jan; 259(1):83-92. PubMed ID: 21671144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor cortical excitability predicts cognitive phenotypes in amyotrophic lateral sclerosis.
    Agarwal S; Highton-Williamson E; Caga J; Howells J; Dharmadasa T; Matamala JM; Ma Y; Shibuya K; Hodges JR; Ahmed RM; Vucic S; Kiernan MC
    Sci Rep; 2021 Jan; 11(1):2172. PubMed ID: 33500476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease.
    Di Lazzaro V; Oliviero A; Pilato F; Saturno E; Dileone M; Marra C; Daniele A; Ghirlanda S; Gainotti G; Tonali PA
    J Neurol Neurosurg Psychiatry; 2004 Apr; 75(4):555-9. PubMed ID: 15026495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic circuitry functioning in patients with vascular cognitive impairment--no dementia.
    Bella R; Cantone M; Lanza G; Ferri R; Vinciguerra L; Puglisi V; Pennisi M; Ricceri R; Di Lazzaro V; Pennisi G
    Brain Stimul; 2016; 9(2):225-33. PubMed ID: 26515786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
    Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcranial magnetic stimulation predicts cognitive decline in patients with Alzheimer's disease.
    Motta C; Di Lorenzo F; Ponzo V; Pellicciari MC; Bonnì S; Picazio S; Mercuri NB; Caltagirone C; Martorana A; Koch G
    J Neurol Neurosurg Psychiatry; 2018 Dec; 89(12):1237-1242. PubMed ID: 30464028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the Alzheimer's Disease Assessment Scale-Cognitive Subscale Useful in Screening for Mild Cognitive Impairment and Alzheimer's Disease? A Systematic Review.
    Park SH; Han KS
    Curr Alzheimer Res; 2022; 19(3):202-211. PubMed ID: 35379127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
    Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
    Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurophysiological measurements of affected and unaffected motor cortex from a cross-sectional, multi-center individual stroke patient data analysis study.
    Simis M; Di Lazzaro V; Kirton A; Pennisi G; Bella R; Kim YH; Takeuchi N; Khedr EM; Rogers LM; Harvey R; Koganemaru S; Turman B; Tarlacı S; Gagliardi RJ; Fregni F
    Neurophysiol Clin; 2016 Feb; 46(1):53-61. PubMed ID: 26970808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity.
    Alagona G; Bella R; Ferri R; Carnemolla A; Pappalardo A; Costanzo E; Pennisi G
    Neurosci Lett; 2001 Nov; 314(1-2):57-60. PubMed ID: 11698146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.